Desktop Site
|
23 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,738.45
+89.83
+0.12 %
Corporate Announcement
Security Code
509079
Company
Gufic Biosciences Ltd
Exchange Received Time
31/07/2020 23:54:02
Exchange Disseminated Time
31/07/2020 23:54:12
Time Taken
00:00:10
Outcome Of The Board Of Directors Meeting Held On July 31, 2020 |
7/31/2020 11:54:04 PM
The Board of Directors of the Company at its Meeting held on July 31, 2020, which commenced at 8:00 p.m. and concluded at 11.40 p.m. on July 31, 2020, inter alia considered and approved the following:
1. The Audited Financial Results for the quarter and financial year ended March 31, 2020. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), enclosed is the said results together with the Auditors Report with unmodified opinion.
2. Recommended Dividend @ 5% i.e. Re. 0.05 per equity share (Face Value of Re. 1/- each) for the financial year ended March 31, 2020, subject to the approval of the Shareholders at the ensuing Annual General Meeting.
3. Approved the updated Code of Conduct for Prevention of Insider Trading in line with the amended provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Attachment
<< Back
Recently Viewed